Abstract
BackgroundGP2015 is an etanercept biosimilar. It has shown an equivalent efficacy, and comparable safety and immunogenicity to ETN in patients with chronic plaque-type psoriasis.1ObjectivesTo compare the efficacy and safety of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have